Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2 Neoplasm Metastasis 2 Breast Neoplasms 2 Vaping 1 Tobacco Use Disorder 1 Stomach Neoplasms 1 Ovarian Neoplasms 1 Multiple Myeloma 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer 1 Granulosa Cell Tumor 1 Endometrial Neoplasms 1 Abiraterone Acetate 1

Interventions

orteronel 1 Nivolumab 1 Ketoconazole 1 BID protein, human 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Granulosa Cell Tumor × BID protein, human × Clear all

NCT02101684 2018-03-05

Greko II

Grupo Español de Tumores Huérfanos e Infrecuentes

Phase 2 Terminated

Granulosa Cell Tumor, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡